After one month from the 1st clinical examination and test of the patients by Echolab OAE Device, patients developed a new changes(increase Amplitude of DPOAE) in OAE record among Study group1, study group 2 (whom received NeurorubineTM injection Ampules) and people in control group(whom did not receive NeurorubineTM injection Ampules), the results recorded were: 14 patients(39%) P-value = 0.000 highly significant (HS), 8 patients(22%) P-value 0.026 significant(S), and two persons (5%) P-value 0.88 non-significant (NS) respectively.
← all excerpts
The use of distortion product otoacoustic emissions (DPOAE) records to estimate effect of vitamin B complex on changing severity of tinnitus.
1
—
—